SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-23-039406
Filing Date
2023-08-14
Accepted
2023-08-14 07:28:42
Documents
71
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc20057263_10q.htm   iXBRL 10-Q 2097029
2 EXHIBIT 31.1 brhc20057263_ex31-1.htm EX-31.1 11371
3 EXHIBIT 31.2 brhc20057263_ex31-2.htm EX-31.2 10809
4 EXHIBIT 32.1 brhc20057263_ex32-1.htm EX-32.1 4829
5 EXHIBIT 32.2 brhc20057263_ex32-2.htm EX-32.2 5005
  Complete submission text file 0001140361-23-039406.txt   8277832

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA roiv-20230630.xsd EX-101.SCH 63349
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE roiv-20230630_cal.xml EX-101.CAL 64427
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE roiv-20230630_def.xml EX-101.DEF 340560
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE roiv-20230630_lab.xml EX-101.LAB 819079
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE roiv-20230630_pre.xml EX-101.PRE 462784
65 EXTRACTED XBRL INSTANCE DOCUMENT brhc20057263_10q_htm.xml XML 1054213
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Filer) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-40782 | Film No.: 231166252
SIC: 2834 Pharmaceutical Preparations